Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2024 Earnings Call Transcript August 1, 2024
Vir Biotechnology, Inc. misses on earnings expectations. Reported EPS is $-1.02 EPS, expectations were $-0.93.
Operator: Hello. Welcome to Vir Biotechnology’s Second Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer...
